Inogen, Inc (INGN): Price and Financial Metrics

Inogen, Inc (INGN): $64.47

2.02 (+3.23%)

POWR Rating

Component Grades














  • Sentiment is the dimension where INGN ranks best; there it ranks ahead of 94.74% of US stocks.
  • INGN's strongest trending metric is Stability; it's been moving up over the last 31 weeks.
  • INGN's current lowest rank is in the Growth metric (where it is better than 14.71% of US stocks).

INGN Stock Summary

  • Price to trailing twelve month operating cash flow for INGN is currently 36.28, higher than 87.14% of US stocks with positive operating cash flow.
  • For INGN, its debt to operating expenses ratio is greater than that reported by just 14.32% of US equities we're observing.
  • With a year-over-year growth in debt of 72.24%, Inogen Inc's debt growth rate surpasses 88.83% of about US stocks.
  • Stocks that are quantitatively similar to INGN, based on their financial statements, market capitalization, and price volatility, are SMSI, PRTS, JAMF, IDN, and VRNT.
  • Visit INGN's SEC page to see the company's official filings. To visit the company's web site, go to

INGN Price Target

For more insight on analysts targets of INGN, see our INGN price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $69.00 Average Broker Recommendation 2 (Hold)

INGN Stock Price Chart Interactive Chart >

Price chart for INGN

INGN Price/Volume Stats

Current price $64.47 52-week high $69.00
Prev. close $62.45 52-week low $26.57
Day low $62.61 Volume 104,500
Day high $64.68 Avg. volume 157,368
50-day MA $62.45 Dividend yield N/A
200-day MA $45.44 Market Cap 1.44B

Inogen, Inc (INGN) Company Bio

Inogen develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and third-party payors in the United States and internationally. The company was founded in 2001 and is based in Goleta, California.

INGN Latest News Stream

Event/Time News Detail
Loading, please wait...

INGN Latest Social Stream

Loading social stream, please wait...

View Full INGN Social Stream

Latest INGN News From Around the Web

Below are the latest news stories about Inogen Inc that investors may wish to consider to help them evaluate INGN as an investment opportunity.

CVS Health (CVS) Deploys Time-Delay Safes in Georgia Pharmacies

CVS Health's (CVS) time-delay safes are anticipated to help reduce robbery incidents.

Yahoo | June 9, 2021

Inogen Announces Appointment of Chief Medical Officer

Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Dr. Stanislav Glezer as Inogen’s Executive Vice President and Chief Medical Officer, effective June 21, 2021.

Yahoo | June 8, 2021

Thermo Fisher (TMO) End Markets Rebound as COVID-19 Cases Drop

In academic and government end markets, Thermo Fisher (TMO) grows on robust customer activity globally.

Yahoo | June 8, 2021

Medtronic (MDT) Progresses in Neuromodulation on New FDA Nod

Medtronic's (MDT) SenSight claims to deliver patient-specific DBS therapy for the treatment of symptoms associated with Parkinson's, dystonia and essential tremor and medically refractory epilepsy.

Yahoo | June 8, 2021

Here's Why You Should Retain CVS Health (CVS) in Your Portfolio

Investors are optimistic about CVS Health (CVS) on solid first-quarter performance and growth in digital health services.

Yahoo | June 8, 2021

Read More 'INGN' Stories Here

INGN Price Returns

1-mo -2.04%
3-mo 24.89%
6-mo 55.91%
1-year 96.23%
3-year -65.08%
5-year 30.98%
YTD 44.29%
2020 -34.61%
2019 -44.97%
2018 4.27%
2017 77.28%
2016 67.55%

Continue Researching INGN

Want to see what other sources are saying about Inogen Inc's financials and stock price? Try the links below:

Inogen Inc (INGN) Stock Price | Nasdaq
Inogen Inc (INGN) Stock Quote, History and News - Yahoo Finance
Inogen Inc (INGN) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.0715 seconds.